Stockreport

Bristol Myers Squibb Announces Positive Top-Line Results from Registrational Phase 2 Study of Luspatercept in Adults with Alpha (a)-Thalassemia

Bristol-Myers Squibb Company  (BMY) 
Last bristol-myers squibb company earnings: 2/6 07:05 am Check Earnings Report
US:NYSE Investor Relations: bms.com/investors.html
PDF Both non-transfusion-dependent and transfusion dependent cohorts met their respective primary and secondary endpoints PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers [Read more]